Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection. (Q53536913)

15 May 2018

title

Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection. (English)

1 reference

15 May 2018

0 references

10

1 reference

15 May 2018

Iole Macchia

object named as

Iole Macchia

6

1 reference

ORCID Public Data File 2021

author name string

Maria Teresa Maggiorella

1

1 reference

15 May 2018

Leonardo Sernicola

2

1 reference

15 May 2018

Federica Crostarosa

3

1 reference

15 May 2018

Roberto Belli

4

1 reference

15 May 2018

Maria Rosaria Pavone-Cossut

5

1 reference

15 May 2018

Stefania Farcomeni

7

1 reference

15 May 2018

Klara Tenner-Racz

8

1 reference

15 May 2018

Paul Racz

9

1 reference

15 May 2018

Fausto Titti

11

1 reference

15 May 2018

publication date

1 August 2007

1 reference

15 May 2018

Journal of Medical Primatology

published in

1 reference

15 May 2018

volume

36

1 reference

15 May 2018

page(s)

180-194

1 reference

15 May 2018

issue

4-5

1 reference

15 May 2018

The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Live attenuated SIV--a model of a vaccine for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

The effect of route of immunization on mucosal immunity and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Dendritic cells in innate immune responses against HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Problems and emerging approaches in HIV/AIDS vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Comparison of the efficacy of early versus late viral proteins in vaccination against SIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.2007.00236.X

10.1111/J.1600-0684.2007.00236.X

21 January 2018

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

17669207

1 reference

15 May 2018